AI scribing is no longer a niche productivity experiment. It is becoming part of mainstream NHS workflow infrastructure — with national guidance from NHS England, a supplier registry requiring medical device accreditation, large-scale deployments reaching the majority of UK primary care, and published evidence of measurable clinical impact.
The most significant signal: Accurx and Tandem Health have partnered to bring Accurx Scribe — powered by Tandem's AI medical scribe — to more than 200,000 NHS staff. Accurx is already embedded in 98% of GP practices as a communication platform. Adding AI scribing into that existing distribution channel gives ambient voice technology an adoption pathway that standalone scribe tools fundamentally cannot replicate.
What Happened
Accurx announced that Accurx Scribe is built on Tandem Health's AI scribe technology, intended for more than 200,000 NHS staff across primary and secondary care. Tandem describes the partnership as bringing real-time transcription, clinical coding suggestions, and document generation to NHS clinicians — with write-back into EMIS and SystmOne, the two dominant GP clinical systems.
Tandem is not a startup experimenting with its first NHS deployment. It is already used by 5,000+ care organisations across Europe, holds CE marking and MHRA registration, and its Coding Assistant holds Europe's first MDR Class IIa certification in its category. Tandem has separately embedded into Doctor Care Anywhere's virtual care platform (60,000+ monthly virtual consultations) and Humanitas — one of Italy's leading hospital groups. The Accurx partnership extends Tandem's reach from specialist early adopters to the mainstream NHS clinical workforce.
Why Accurx Distribution Matters
Distribution is the difference between a tool that clinicians might use and a tool that clinicians actually use. Accurx is already embedded in the communication workflow of virtually every GP practice in England — the platform through which practices send patient messages, manage online consultations, coordinate referrals, and communicate with patients. Adding AI scribing inside Accurx means the scribe is not a new app to download, a new login to remember, or a new workflow to learn. It is a feature inside a tool clinicians already open dozens of times per day.
This distribution advantage is structural and difficult to replicate. Standalone scribe tools — however technically strong — must persuade each practice to adopt a new product, navigate local governance approval, configure EHR integration, train staff, and build a new daily habit from scratch. Accurx Scribe inherits an existing installed base, existing governance relationships, existing EHR integration infrastructure, and existing daily usage patterns. The adoption friction is dramatically lower.
For the broader AI scribe market, this sets a precedent: the winning scribe may not be the one with the best model or the most features, but the one with the best distribution into existing clinical workflows.
What This Says About the Market
AI scribing is transitioning from pilot to infrastructure. Three concurrent national-level developments confirm this.
National guidance. NHS England published comprehensive guidance on AI-enabled ambient scribing products in April 2025, updated to Version 2 in April 2026. The guidance covers implementation, clinical safety, information governance, and integration — aligned with the NHS England AVT Supplier Registry. Separate information governance guidance, reviewed by the ICO and the National Data Guardian, was published with a template DPIA in March 2026. The AVID community, run independently by THIS Institute in partnership with The Health Foundation, supports organisations shaping AVT adoption across the NHS.
Evidence of clinical impact. A major NHS England-sponsored study showed a 23.5% increase in direct patient interaction time during appointments and an 8.2% reduction in overall appointment length when AI scribes were used. For a health service processing 35 million GP appointments in March 2026 alone, those percentages translate into millions of recovered clinical minutes annually.
Supplier registry. The AVT Supplier Registry, launched January 2026, requires suppliers to hold Class 1 Medical Device accreditation and current DTAC assessment. Applications reopened February 2026 and remain open indefinitely. East Lancashire Hospitals NHS Trust is hosting a national programme to deploy AVT across the NHS in England — reflecting system-level commitment to scaling the technology.
What Clinicians Should Understand Before Using AI Scribes
Consent and transparency. Explicit consent is not legally required for ambient scribes used in individual care. But transparency is essential — clinicians must inform patients at the start of any session that a scribe is in use. NHS England provides suggested wording that can be adapted locally.
Clinical responsibility. Healthcare professionals retain full responsibility for the accuracy of clinical records. Outputs must be checked and corrected before being saved to the patient record. The scribe drafts. The clinician verifies and owns.
Data minimisation. Audio recordings and transcripts should typically be deleted once a verified summary has been produced. Retention requires documented justification.
Coding verification. Scribes that generate SNOMED CT suggestions create structured data in the permanent record. Clinicians must verify that codes reflect what was actually assessed — including the critical distinction between confirmed, suspected, excluded, and historical conditions.
Local governance. Organisations should complete a DPIA (NHS England provides a template), ensure data processing agreements are in place, and verify the product meets AVT Supplier Registry standards.
How This Differs from Clinical Search and Decision Support
AI scribes sit inside the consultation — capturing what happens and generating documentation. Clinical search and evidence tools sit around clinical uncertainty — answering the questions that arise before, during, or after a clinical decision. Local guideline platforms organise institutional knowledge — protocols, formularies, referral pathways.
A clinician may use Accurx Scribe to document the consultation and Ask iatroX to verify the management plan against UK guidelines. The scribe writes the note. The clinical knowledge tool checks the reasoning. Different tools, different moments, complementary functions.
The AI Consultation Stack
The clinical consultation is increasingly supported by multiple AI layers: intake, scribing, coding, guideline checking, safety-netting, referral/message generation, CPD and learning, and audit/governance. Different tools serve different layers. iatroX is positioned at the clinical knowledge, verification, and learning layers.
Where iatroX Sits
Some AI tools help clinicians write the note. Others help them find guidance. iatroX is built around the clinical question itself: the answer, the source, the calculator, the learning point, and the CPD record. AI scribes may help write the consultation. iatroX helps clinicians check the clinical question, cite the source, calculate the score, and save the learning.
Use iatroX after the note, during the question, or before the referral →